Bleeding Risk, Dual Antiplatelet Therapy Cessation, and Adverse Events After Percutaneous Coronary Intervention The PARIS Registry

Sorrentino, S; Sartori, S; Baber, U; Claessen, BE; Giustino, G; Chandrasekhar, J; Chandiramani, R; Cohen, DJ; Henry, TD; Guedeney, P; Ariti, C; Dangas, G; Gibson, CM; Krucoff, MW; Moliterno, DJ; Colombo, A; Vogel, B; Chieffo, A; Kini, AS; Witzenbichler, B; Weisz, G; Steg, PG; Pocock, S; Urban, P; Mehran, R

Mehran, R (corresponding author), Mt Sinai Hosp, One Gustave L Levy Pl,Box 1030, New York, NY 10029 USA.

CIRCULATION-CARDIOVASCULAR INTERVENTIONS, 2020; 13 (4):

Abstract

Background: Whether the underlying risk of bleeding influences the associations between patterns of dual antiplatelet therapy (DAPT) cessation and adv......

Full Text Link